SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $90.93 | 52-week high | $105.47 |
| Prev. close | $91.28 | 52-week low | $81.14 |
| Day low | $90.36 | Volume | 3,339,804 |
| Day high | $91.72 | Avg. volume | 9,428,362 |
| 50-day MA | $97.38 | Dividend yield | 0.14% |
| 200-day MA | $95.03 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Biotech |
| Assets Under Management (AUM) | 6.37M |
| Net Asset Value (NAV) | $91.28 |
| Options? | Yes |
| Total Holdings | 148 |
XBI Top Holdings
| Symbol | Company | % of Total |
| NTRA | NATERA INC | 3.48% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 3.07% |
| GILD | GILEAD SCIENCES INC | 3.06% |
| UTHR | UNITED THERAPEUTICS CORP | 2.96% |
| INCY | INCYTE CORP | 2.94% |
| SRPT | SAREPTA THERAPEUTICS INC | 2.67% |
| INSM | INSMED INC | 2.59% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2.51% |
| ABBV | ABBVIE INC | 2.46% |
| EXAS | EXACT SCIENCES CORP | 2.38% |
XBI Price Returns
| 1-mo | -5.52% |
| 3-mo | -7.88% |
| 6-mo | -1.35% |
| 1-year | 3.92% |
| 3-year | N/A |
| 5-year | -7.28% |
| YTD | 1.98% |
| 2023 | 7.60% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
| 2019 | 32.56% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||